On August 29, The Life Sciences Discovery Fund (LSDF) announced nearly $750,000 in Proof of Concept grants to Washington state for-profit and non-profit organizations to promote translation of health-related technologies from the laboratory to the commercial marketplace. Nexgenia’s project to develop and validate technology for increasing the speed and..
Read more
In June 2014, Drs. Thomas Schulte and Barrett Nehilla traveled to Dresden, Germany to present recent results on the synthesis of stimuli-responsive magnetic nanoparticles at the 10th International Conference on the Scientific and Clinical Applications of Magnetic Carriers. They also presented at the TechConnect World Innovation Conference and Expo in..
Read more
Nexgenia CEO, Dr. Thomas Schulte, and Senior Scientist, Dr. Barrett Nehilla attended the 2014 Emerging Clinical and Laboratory Diagnostics in San Jose, CA in April. This conference is the successor to the long-standing Oak Ridge Conference series. They presented a poster entitled “Transitions of magnetic nano- to micro-particles facilitate bioseparation..
Read more
Nexgenia scientist Barrett J. Nehilla gave an oral and poster presentation at the 45th Annual AACC Oak Ridge conference in Baltimore, MD on April 18, 2021. The presentation was titled “Stimuli-responsive reagents enable rapid biomarker capture and separation”.
Nexgenia scientist Barrett J. Nehilla partnered with Nexgenia collaborators from the University of Washington to publish a stimuli-responsive polymer composition for efficient biomolecule conjugations. See below for reference. Roy, D., B.J. Nehilla, J. J. Lai, P. S. Stayton. Stimuli-responsive polymer-antibody conjugates via RAFT and tetrafluorophenyl active ester chemistry. ACS Macro Lett., 2013, 2 (2),..
Read more
With support from the Life Sciences Discovery Fund of the state of Washington, CSIRO is putting our RAFT technology to work with U.S. startup Nexgenia Based in Seattle, Washington, Nexgenia is developing novel polymeric in-vitro reagents that are game-changers – creating higher speed and sensitivity attributes for new diagnostics across..
Read more
